Category Archives: TRI

Mylan Presents Equivalence and Device Usability Data on Wixela™ Inhub™ Compared to Advair Diskus® at American Thoracic Society International Conference

HERTFORDSHIRE, England, and PITTSBURGH, May 18, 2019 /PRNewswire/ — Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced four scientific abstracts from the Wixela™ Inhub™ (fluticasone propionate and salmeterol inhalation powder, USP) development program that will be… Read more about Mylan Presents Equivalence and Device

MindSciences’ To Quit® smoking cessation app study is first to identify the neural mechanisms of a digital therapeutic mindfulness intervention for smoking cessation at the individual level

WORCESTER, Mass., May 16, 2019 /PRNewswire/ — In a National Institutes of Health-funded randomized controlled clinical trial, To Quit, MindSciences’ smoking cessation app, has shown a dose-dependent relationship between app use and reduction in cigarette smoking. The trial involved 67… Read more about MindSciences’ To

Mallinckrodt Completes Enrollment of Phase 3 Terlipressin CONFIRM Trial

STAINES-UPON-THAMES, United Kingdom, May 14, 2019 /PRNewswire/ — Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced that the company has achieved target enrollment of 300 participants in its Phase 3 CONFIRM clinical study to evaluate the… Read more about Mallinckrodt Completes